Analyst consensus — SARTORIUS STED BIO
FR0013154002 · Medical Equipment & Services
Current price
162,30 €
Median target
231,00 €
Gap
+42,3%
Low target
85,00 €
High target
262,00 €
30-day trend
≈ -1,7%
Consensus
Buy (45.5%), Outperform (27.3%), Overweight (9.1%), Accumuler (9.1%), Hold (9.1%)
Latest banks : Intron Health Research (24/04/2026), Nephron Research (24/04/2026), Goldman Sachs (30/03/2026)
Consensus evolution
| Period | Median target | Consensus |
|---|---|---|
| Today | 231,00 € | Buy (45.5%), Outperform (27.3%), Overweight (9.1%), Accumuler (9.1%), Hold (9.1%) |
| 7 days ago | 233,00 € | Buy (33.3%), Outperform (33.3%), Overweight (11.1%), Accumuler (11.1%), Hold (11.1%) |
| 14 days ago | 233,00 € | Buy (33.3%), Outperform (33.3%), Overweight (11.1%), Accumuler (11.1%), Hold (11.1%) |
| 21 days ago | 233,00 € | Buy (33.3%), Outperform (33.3%), Overweight (11.1%), Accumuler (11.1%), Hold (11.1%) |
Some analysts
| Analyst | Target | Rating | Date |
|---|---|---|---|
| Intron Health Research | 230,00 € | Buy | Apr 24, 2026 |
| Nephron Research | 240,00 € | Buy | Apr 24, 2026 |
| Goldman Sachs | 214,00 € | Buy | Mar 30, 2026 |
| Barclays | 220,00 € | Overweight | Mar 20, 2026 |
Gratuit · Chaque matin
Les signaux techniques du marché, avant l'ouverture.
Dynamiques haussières et baissières, changements d'analystes, valeurs à surveiller — calculés automatiquement sur les données Euronext.
✓ Avant 9h chaque matin
✓ Données Euronext
✓ Analyse automatique IA
Données indicatives. Aucun conseil en investissement. Désinscription à tout moment.
